TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Microbiotech/se AB
Closing information (x1000 DKK)
Closing information | 2024/04 | 2023/04 | 2022/04 |
Turnover |
1,972
|
1,750
|
2,306 |
Financial expenses |
0
|
1
|
0 |
Earnings before taxes |
157
|
14
|
-45 |
EBITDA |
150
|
15
|
-45 |
Total assets |
1,452
|
1,476
|
1,830 |
Current assets |
1,452
|
1,476
|
1,830 |
Current liabilities |
171
|
263
|
499 |
Equity capital |
1,230
|
1,150
|
1,250 |
- share capital |
209
|
217
|
238 |
Employees (average) |
4
|
3
|
4 |
Financial ratios
Fiscal year | 2024/04 | 2023/04 | 2022/04 |
Solvency |
84.7%
|
77.9%
|
68.3% |
Turnover per employee |
493
|
583
|
576 |
Profit as a percentage of turnover |
8.0%
|
0.8%
|
-2.0% |
Return on assets (ROA) |
10.8%
|
1.0%
|
-2.5% |
Current ratio |
849.1%
|
561.2%
|
366.7% |
Return on equity (ROE) |
12.8%
|
1.2%
|
-3.6% |
Change turnover |
284
|
-353
|
473 |
Change turnover % |
17%
|
-17%
|
26% |
Chg. No. of employees |
1
|
-1
|
4 |
Chg. No. of employees % |
33%
|
-25% |
Total value of public sale
Fiscal year | 2024/04 | 2023/04 | 2022/04 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.